CBS and hepatocellular carcinoma: Studies have also found that human HCC cells with high CBS expression had low sensitivity to sunitinib and doxorubicin (DOX), while the knockdown of CBS markedly increased the sensitivity of HCC fineness to DOX and sunitinib.